Dr. Maris Stella Legarda, MD

Dr. Legarda practices at Montage Medical Group in Monterey, California.

Dr. Legarda's NPI, 1659331296, was assigned on March 27, 2006. Dr. Legarda graduated from Saint Louis University, Philipppines in 1982. Dr. Legarda holds California license C52834.

Dr. Legarda's primary practice is Montage Medical Group, at 23845 Holman Hwy, Monterey, CA 93940 in Monterey County. The practice phone is (831) 658-3639.

Dr. Legarda's primary practice is Montage Medical Group in Monterey, California. Dr. Legarda is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is Montage Medical Group. Dmand AI also links Dr. Legarda to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Legarda practices, 3 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Legarda's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Legarda is board certified in neurology with special qualification in child neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Legarda's licenses on file in 2 states: California and South Carolina.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, encephalopathy, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Legarda treats.

CMS data shows 1,515 Medicare services from Dr. Legarda across 12 procedure codes in 2024, for 374 Medicare patients. Medicare paid $108,685 for them.

CMS counts 374 Medicare patients who saw Dr. Legarda in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Legarda's median patient age at 37, with 64% women.

In 2024, Dr. Legarda wrote 1,350 Medicare Part D claims for 157 patients. 86% of them were for generic drugs. CMS names the drug for 1,115 of them, across 36 drugs with 11 or more claims each, at $230,475 in total drug cost. In 2023, CMS named 1,357 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Legarda for performance year 2024, reported as part of a group. Dr. Legarda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Legarda as offering telehealth.

CMS Open Payments shows 91 general payments to Dr. Legarda from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. LivaNova PLC paid the most, $1,916.

Dr. Legarda graduated from Saint Louis University, Philipppines in 1982.

Dr. Legarda is in network with 13 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.